Surmodics, Inc [SRDX] stock prices are up 12.32% to $36.0 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SRDX shares have gain 19.17% over the last week, with a monthly amount glided 24.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surmodics, Inc [NASDAQ: SRDX] stock has seen the most recent analyst activity on March 07, 2025, when Lake Street upgraded its rating to a Buy but kept the price target unchanged to $43 for it. Previously, Needham upgraded its rating to Buy on June 13, 2023, and kept the price target unchanged to $36. On February 13, 2023, downgrade downgraded it’s rating to Hold. Needham upgraded its rating to a Buy. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to Hold for this stock on November 01, 2019, and downed its price target to $50. In a note dated August 01, 2019, Needham reiterated an Buy rating on this stock and boosted its target price from $65 to $68.
The stock price of Surmodics, Inc [SRDX] has been fluctuating between $26.00 and $41.88 over the past year. Currently, Wall Street analysts expect the stock to reach $39.5 within the next 12 months. Surmodics, Inc [NASDAQ: SRDX] shares were valued at $36.0 at the most recent close of the market. An investor can expect a potential return of 9.72% based on the average SRDX price forecast.
Analyzing the SRDX fundamentals
The Surmodics, Inc [NASDAQ:SRDX] reported sales of 121.58M for trailing twelve months, representing a drop of -12.12%. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.17 and Total Capital is -0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.18 points at the first support level, and at 30.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.48, and for the 2nd resistance point, it is at 38.96.
Ratios To Look Out For
It’s worth pointing out that Surmodics, Inc [NASDAQ:SRDX]’s Current Ratio is 5.14. Further, the Quick Ratio stands at 3.99, while the Cash Ratio is 2.09. Considering the valuation of this stock, the price to sales ratio is 4.23, the price to book ratio is 4.67.
Transactions by insiders
Recent insider trading involved Arens Timothy J., Chief Financial Officer, that happened on Nov 26 ’24 when 7009.0 shares were sold. Officer, TIMOTHY ARENS completed a deal on Nov 26 ’24 to buy 7009.0 shares.
